Search research articles
Contact Us
Filters
Showing results (141-150 of 276) with videos related to
Page
of 28
Sort By:
Leukemia Research
|
March 14, 2024
Efficacy and safety of bosutinib in patients treated with prior imatinib and/or dasatinib and/or nilotinib: Subgroup analyses from the phase 4 BYOND study
B Douglas Smith, Tim H Brümmendorf, Gail J Roboz, et al.
Cold Spring Harbor Perspectives in Biology
|
April 3, 2019
A Chemical Biology Approach to the Chaperome in Cancer-HSP90 and Beyond
Tony Taldone, Tai Wang, Anna Rodina, et al.
Leukemia & Lymphoma
|
October 25, 2016
Differential response to hypomethylating agents based on sex: a report on behalf of the MDS Clinical Research Consortium (MDS CRC)
Amy E DeZern, Amer M Zeidan, John Barnard, et al.
Leukemia Research
|
March 11, 2021
A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival
Jacqueline S Garcia, Ronan T Swords, Gail J Roboz, et al.
Leukemia Research
|
April 26, 2021
Corrigendum to "A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival" [Leukemia Res. 104 March (2021)]
Jacqueline S Garcia, Ronan T Swords, Gail J Roboz, et al.
Leukemia & Lymphoma
|
January 15, 2025
High incidence of multi-joint osteonecrosis in first year following treatment for acute lymphoblastic leukemia
Alison K Heilbronner, Olivia Blumberg, Alexandra Krez, et al.
The Lancet. Haematology
|
December 5, 2024
Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemia
Ibrahim Aldoss, Gail J Roboz, Renato Bassan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2006
Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma
John D Roberts, Mitchell R Smith, Eric J Feldman, et al.
Haematologica
|
May 5, 2018
Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia
Gail J Roboz, Ellen K Ritchie, Yulia Dault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2006
Phase I/II study of continuous-infusion troxacitabine in refractory acute myeloid leukemia
Gail J Roboz, Francis J Giles, Ellen K Ritchie, et al.
Page
of 28
Search research articles
Search
Showing results (141-150 of 276) with videos related to
Sort By:
Page
of 28
Leukemia Research
|
March 14, 2024
Efficacy and safety of bosutinib in patients treated with prior imatinib and/or dasatinib and/or nilotinib: Subgroup analyses from the phase 4 BYOND study
B Douglas Smith, Tim H Brümmendorf, Gail J Roboz, et al.
Cold Spring Harbor Perspectives in Biology
|
April 3, 2019
A Chemical Biology Approach to the Chaperome in Cancer-HSP90 and Beyond
Tony Taldone, Tai Wang, Anna Rodina, et al.
Leukemia & Lymphoma
|
October 25, 2016
Differential response to hypomethylating agents based on sex: a report on behalf of the MDS Clinical Research Consortium (MDS CRC)
Amy E DeZern, Amer M Zeidan, John Barnard, et al.
Leukemia Research
|
March 11, 2021
A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival
Jacqueline S Garcia, Ronan T Swords, Gail J Roboz, et al.
Leukemia Research
|
April 26, 2021
Corrigendum to "A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival" [Leukemia Res. 104 March (2021)]
Jacqueline S Garcia, Ronan T Swords, Gail J Roboz, et al.
Leukemia & Lymphoma
|
January 15, 2025
High incidence of multi-joint osteonecrosis in first year following treatment for acute lymphoblastic leukemia
Alison K Heilbronner, Olivia Blumberg, Alexandra Krez, et al.
The Lancet. Haematology
|
December 5, 2024
Frontline treatment of adults with newly diagnosed B-cell acute lymphoblastic leukaemia
Ibrahim Aldoss, Gail J Roboz, Renato Bassan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2006
Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma
John D Roberts, Mitchell R Smith, Eric J Feldman, et al.
Haematologica
|
May 5, 2018
Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia
Gail J Roboz, Ellen K Ritchie, Yulia Dault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2006
Phase I/II study of continuous-infusion troxacitabine in refractory acute myeloid leukemia
Gail J Roboz, Francis J Giles, Ellen K Ritchie, et al.
Page
of 28